Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression
Authors
Keywords
T cells, Cytokines, Lesions, Mycobacterium ulcerans, Tissue repair, Immune response, Antibiotics, Blood
Journal
PLoS Neglected Tropical Diseases
Volume 11, Issue 2, Pages e0005415
Publisher
Public Library of Science (PLoS)
Online
2017-02-28
DOI
10.1371/journal.pntd.0005415
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
- (2016) Yves Thierry Barogui et al. PLoS Neglected Tropical Diseases
- Elevated expression of T-bet in mycobacterial antigen-specific CD4+ T cells from patients with tuberculosis
- (2015) Bingfen Yang et al. CELLULAR IMMUNOLOGY
- Effectiveness of Routine BCG Vaccination on Buruli Ulcer Disease: A Case-Control Study in the Democratic Republic of Congo, Ghana and Togo
- (2015) Richard Odame Phillips et al. PLoS Neglected Tropical Diseases
- Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography
- (2015) Anita Wadagni et al. PLoS Neglected Tropical Diseases
- Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes
- (2015) Daniel P. O’Brien et al. PLoS Neglected Tropical Diseases
- Rapid Detection and Immune Characterization of Mycobacterium abscessus Infection in Cystic Fibrosis Patients
- (2015) Mathis Steindor et al. PLoS One
- Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients
- (2014) Patricia Bourguignon et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Combined Inflammatory and Metabolic Defects Reflected by Reduced Serum Protein Levels in Patients with Buruli Ulcer Disease
- (2014) Richard O. Phillips et al. PLoS Neglected Tropical Diseases
- Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study
- (2014) Quentin B Vincent et al. Lancet Global Health
- Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease
- (2013) Richard O. Phillips et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulceransinfections
- (2013) Daniel P O’Brien et al. BMC INFECTIOUS DISEASES
- Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease
- (2011) Alexandre Harari et al. NATURE MEDICINE
- Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
- (2011) Marie-Thérèse Ruf et al. PLoS Neglected Tropical Diseases
- Spontaneous Clearance of Mycobacterium ulcerans in a Case of Buruli Ulcer
- (2011) Claire L. Gordon et al. PLoS Neglected Tropical Diseases
- Clinical Efficacy of Combination of Rifampin and Streptomycin for Treatment of Mycobacterium ulcerans Disease
- (2010) F. S. Sarfo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society
- (2010) R. Mallone et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Oral Treatment for Mycobacterium ulcerans Infection: Results From a Pilot Study in Benin
- (2010) Annick Chauty et al. CLINICAL INFECTIOUS DISEASES
- T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients
- (2010) X.-Y. He et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- MycobacteriumulceransTriggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression
- (2010) Alexandra G. Fraga et al. INFECTION AND IMMUNITY
- Tuberculin-Specific T Cells Are Reduced in Active Pulmonary Tuberculosis Compared to LTBI or Status Post BCG Vaccination
- (2010) Mathias Streitz et al. JOURNAL OF INFECTIOUS DISEASES
- Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
- (2010) Willemien A Nienhuis et al. LANCET
- Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment
- (2010) James M. Young et al. PLoS One
- Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review
- (2010) Richard W. Merritt et al. PLoS Neglected Tropical Diseases
- Comparative Study of the Sensitivity of Different Diagnostic Methods for the Laboratory Diagnosis of Buruli Ulcer Disease
- (2009) Karl‐Heinz Herbinger et al. CLINICAL INFECTIOUS DISEASES
- Pattern and diversity of cytokine production differentiates betweenMycobacterium tuberculosisinfection and disease
- (2009) Jayne S. Sutherland et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sensitivity of PCR Targeting Mycobacterium ulcerans by Use of Fine-Needle Aspirates for Diagnosis of Buruli Ulcer
- (2009) R. O. Phillips et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer Disease
- (2009) Richard Phillips et al. JOURNAL OF INFECTIOUS DISEASES
- Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer
- (2009) Manuel T Silva et al. LANCET INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started